Infusion site swelling: Which Medications Cause It? (5,214 Reports Across 139 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Infusion site swelling has been reported as an adverse event with 139 different drugs in the FDA's FAERS database, with 5,214 total reports. 110 of these reports resulted in death.The drugs most commonly associated with Infusion site swelling are HUMAN IMMUNOGLOBULIN G, TREPROSTINIL, and HUMAN IMMUNOGLOBULIN G\HYALURONIDASE.
5,214
Total Reports
139
Drugs Involved
110
Deaths
1,146
Hospitalizations
51.9 yrs
Average Patient Age
74.4% / 25.6%
Female / Male
Which Drugs Cause Infusion site swelling Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| HUMAN IMMUNOGLOBULIN G | 1,772 | 2.5% | 35 | 315 | 5 |
| TREPROSTINIL | 1,686 | 1.8% | 29 | 386 | 18 |
| HUMAN IMMUNOGLOBULIN G\HYALURONIDASE | 241 | 8.2% | 10 | 77 | 0 |
| HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | 194 | 4.4% | 5 | 25 | 0 |
| AMBRISENTAN | 173 | 0.2% | 3 | 66 | 5 |
| INFLIXIMAB-DYYB | 100 | 0.4% | 3 | 27 | 1 |
| INFLIXIMAB | 98 | 0.1% | 4 | 24 | 0 |
| MACITENTAN | 96 | 0.2% | 8 | 51 | 0 |
| VEDOLIZUMAB | 57 | 0.1% | 3 | 17 | 0 |
| FOSCARBIDOPA\FOSLEVODOPA | 55 | 1.7% | 3 | 24 | 2 |
| LECITHIN\POLOXAMER 407 | 50 | 28.7% | 0 | 10 | 0 |
| SELEXIPAG | 46 | 0.3% | 2 | 15 | 0 |
| RIOCIGUAT | 39 | 0.2% | 3 | 22 | 1 |
| ALPHA.1-PROTEINASE INHIBITOR HUMAN | 36 | 0.5% | 1 | 7 | 0 |
| BOSENTAN | 34 | 0.2% | 3 | 17 | 1 |
| PREDNISONE | 34 | 0.0% | 0 | 15 | 2 |
| RITUXIMAB | 33 | 0.0% | 0 | 24 | 0 |
| ALEMTUZUMAB | 31 | 0.2% | 0 | 12 | 0 |
| EPOPROSTENOL | 31 | 0.2% | 2 | 25 | 1 |
| FERRIC CARBOXYMALTOSE | 31 | 0.4% | 0 | 2 | 0 |
Top 3 Drugs Associated With Infusion site swelling
1,772 reports
1,686 reports
241 reports